(Q71596768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

A B Grey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J P Stapleton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M C Evans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M A Tatnell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

R W Ames

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

I R Reid

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

636-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of osteoporosis

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Treatment of postmenopausal osteoporosis with transdermal estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

The effect of postmenopausal estrogen therapy on bone density in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Effects of tamoxifen on spinal bone density in women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Does long-term administration of tamoxifen affect bone mineral density?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Effect of calcium supplementation on bone loss in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Risk of endometrial cancer after tamoxifen treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Hormone therapy to prevent disease and prolong life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

Symptoms associated with tamoxifen treatment in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980251-4

10.1016/S0002-9343(99)80251-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7503087%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference